CCC

Citius Oncology, Inc.

No trades
See on Supercharts

CTOR fundamentals

Citius Oncology, Inc. earnings per share and revenue

CTOR earnings per share for the last quarter are -0.08 USD whereas the estimation was -0.08 USD which accounts for 0.00% surprise. Company revenue for the same period amounts to 0.00 USD despite the estimated figure of 0.00 USD. Estimated earnings per share for the next quarter are -0.06 USD, and revenue is expected to reach 0.00 USD. Also watch annual changes over time to get a bigger picture of CTOR earnings per share and revenue dynamics.

Next report date
Report period
EPS estimate
Revenue estimate
EPS
‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Revenue
‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise